Surgery Partners, Inc. (SGRY) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Surgery Partners, Inc. (SGRY) stock forecast summary
Our AI scores Surgery Partners, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Surgery Partners, Inc. is a mid-cap company with a market capitalization of $3.04B. It ranks number 4 by market capitalization among the 6 Services-General Medical & Surgical Hospitals, NEC issuers in our coverage with a current forecast.
For SGRY, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 18.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 20.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SGRY included.
SGRY price chart and AI forecast
How SGRY ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Surgery Partners, Inc. (SGRY) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-General Medical & Surgical Hospitals, NEC peers listed below that report each metric.
Valuation & Market
| Metric | SGRY | Rank |
|---|---|---|
| Market Cap | $3.04B | 4/6 |
| P/B Ratio | 1.82x | – |
| EPS | $-0.71 | – |
| Book Value/Share | $12.76 | – |
| Revenue/Share | $25.71 | – |
| FCF/Share | $1.43 | – |
Profitability & Margins
| Metric | SGRY | Rank |
|---|---|---|
| ROE | -5.3% | – |
| ROA | -1.1% | – |
| ROIC | 5.1% | – |
| Operating Margin | 11.4% | – |
| Net Margin | -2.6% | 5/5 |
| EBT Margin | 11.3% | 3/6 |
| Tax Rate | 5.4% | – |
Financial Health
| Metric | SGRY | Rank |
|---|---|---|
| Current Ratio | 1.95x | 2/6 |
| Quick Ratio | 1.78x | – |
| D/E Ratio | 2.96x | – |
| Financial Leverage | 4.82x | – |
| Interest Coverage | 0.4x | – |
| Working Capital | $548M | 5/6 |
Cash Flow
| Metric | SGRY | Rank |
|---|---|---|
| Operating Cash Flow | $258M | 5/6 |
| Free Cash Flow | $188M | 4/5 |
| Capital Spending | -$70M | 1/5 |
| OCF Growth YoY | -2.2% | 4/6 |
| FCF Growth YoY | 7.0% | 3/5 |
| FCF/Sales | 5.6% | 4/5 |
| CapEx/Sales | 2.1% | 5/5 |
Operational Efficiency
| Metric | SGRY | Rank |
|---|---|---|
| Asset Turnover | 0.42x | 5/5 |
| Receivables Turnover | 5.5x | 6/6 |
| Fixed Assets Turnover | 8.2x | 1/6 |
| Days Sales Outstanding | 67 days | 1/6 |
Income Statement
| Metric | SGRY | Rank |
|---|---|---|
| Total Revenue | $3.37B | 6/6 |
| Operating Income | $384M | – |
| Net Income | -$89M | 5/5 |
Dividend & Shareholder Information
| Metric | SGRY | Rank |
|---|---|---|
| Shares Outstanding | 131M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.13B | 14.0% of assets |
| Cash & Short-term Investments | $217M | 2.7% of assets |
| Accounts Receivable | $617M | 7.7% of assets |
| Inventory | $99M | 1.2% of assets |
| Total Liabilities | $4.95B | 61.5% of assets |
| Short-term Debt | $403M | 5.0% of assets |
SGRY quarterly financials and insider trading
Surgery Partners, Inc. (SGRY) industry peers
Companies classified under the same SEC industry code as Surgery Partners, Inc. (Services-General Medical & Surgical Hospitals, NEC): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere SGRY sits on the market map
Surgery Partners, Inc. (SGRY) stock news
Loading...
Surgery Partners, Inc. (SGRY) stock forecast FAQ
What is the Surgery Partners, Inc. (SGRY) stock forecast?
Our AI scores Surgery Partners, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Surgery Partners, Inc. stock predictions?
For SGRY, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 18.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 20.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Surgery Partners, Inc. forecasts updated?
Surgery Partners, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Surgery Partners, Inc.'s industry peers?
6 issuers in our coverage, SGRY included, share the SEC industry code Services-General Medical & Surgical Hospitals, NEC. The largest are: Hca Healthcare, Inc. (HCA), Tenet Healthcare Corp (THC), Universal Health Services Inc (UHS), Ardent Health, Inc. (ARDT), Community Health Systems Inc (CYH).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.